Form 4: Aveanna Chief Compliance Officer Sells Shares for Tax
Insider Transaction Report
Aveanna Healthcare Holdings' Chief Compliance Officer, Patrick A. Cunningham, sold shares to cover tax obligations from vested equity awards.
Summary
- Patrick A. Cunningham, Chief Compliance Officer of Aveanna Healthcare Holdings, Inc. (AVAH), reported sales of common stock.
- These sales were executed to satisfy tax obligations related to the vesting of equity awards.
- The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
- On December 30, 2025, 11,839 shares were sold at a weighted average price of $8.3556.
- On December 31, 2025, 11,731 shares were sold at a weighted average price of $8.1777.
- On January 2, 2026, 12,445 shares were sold at a weighted average price of $7.8452.
- Following these transactions, Cunningham beneficially owns 293,354 shares of common stock.
- The reported beneficial ownership includes 1,500 shares acquired under the Registrant's Employee Stock Purchase Plan (ESPP) in July 2025.
Sentiment
Score: 6
Explanation: The sales are routine 'sell to cover' transactions for tax obligations related to vested equity awards, which are generally pre-planned and not indicative of a change in management's confidence in the company. The underlying vesting is a positive for the officer.
Positives
- The underlying event, the vesting of equity awards, is a positive for the reporting person, indicating compensation and retention.
- The transactions were conducted under a Rule 10b5-1(c) plan, suggesting a pre-planned and non-discretionary sale.
Negatives
- The sales reduce the direct beneficial ownership of common stock by a key officer.
- The weighted average sale prices declined across the three transaction dates ($8.3556, $8.1777, $7.8452).
Future Outlook
Not applicable. This filing is a report of past insider transactions and does not contain forward-looking statements or guidance.
Industry Context
Not applicable. This Form 4 filing details specific insider transactions and does not provide broader industry context.
Stakeholder Impact
- Shareholders: A minor increase in the public float of shares, but the reason for the sale (tax obligations) typically mitigates concerns about management's confidence.
- Employees: The vesting of equity awards is a positive for the reporting person as an employee, representing a form of compensation.
Key Dates
| Date | Description |
|---|---|
| July 2025 | 1,500 shares acquired under the Registrant's Employee Stock Purchase Plan (ESPP). |
| 12/30/2025 | Sale of 11,839 shares of common stock at $8.3556 per share. |
| 12/31/2025 | Sale of 11,731 shares of common stock at $8.1777 per share. |
| 01/02/2026 | Sale of 12,445 shares of common stock at $7.8452 per share. |
Recommendation
holdThese are routine, pre-planned sales by an insider to cover tax liabilities associated with vested equity awards. Such transactions are common and generally do not reflect a discretionary decision by the insider to sell due to concerns about the company's future prospects. Therefore, this filing alone does not provide a basis for changing an investment recommendation.
Keywords
Aveanna Healthcare, AVAH, Form 4, Insider Transaction, Stock Sale, Equity Awards, Chief Compliance Officer, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.